Tantravahi, S. K., Szankasi, P., Khorashad, J. S., Dao, K., Kovacsovics, T., Kelley, T. W., & Deininger, M. W. (2016). A phase II study of the efficacy, safety, and determinants of response to 5-azacitidine (Vidaza(®)) in patients with chronic myelomonocytic leukemia. Leuk Lymphoma.

Tantravahi, Srinivas K., Philippe Szankasi, Jamshid S. Khorashad, Kim-Hien Dao, Tibor Kovacsovics, Todd W. Kelley, und Michael W. Deininger. "A Phase II Study of the Efficacy, Safety, and Determinants of Response to 5-azacitidine (Vidaza(®)) in Patients With Chronic Myelomonocytic Leukemia." Leuk Lymphoma 2016.

Tantravahi, Srinivas K., et al. "A Phase II Study of the Efficacy, Safety, and Determinants of Response to 5-azacitidine (Vidaza(®)) in Patients With Chronic Myelomonocytic Leukemia." Leuk Lymphoma 2016.